Dr. Benjamin Dehay received his PhD from the University of Paris VI in 2007, under the supervision of Dr. Anne Bertolotti, in the context of Huntington’s disease. He was then trained as a postdoctoral fellow in the laboratory of Dr. Miquel Vila, where his work mainly focused on the molecular mechanisms of neuronal cell death and the mechanism and significance of Lewy body formation in Parkinson’s disease (PD). Since 2010, he has been working in the Institute of Neurodegenerative Diseases Research Group of Dr. Erwan Bezard, first as a postdoctoral fellow and later as an Independent Investigator. The main focus of Dr Dehay’s research is to study of the role of the lysosomal dysfunction in PD, and the development of new neuroprotective/disease-modifying therapeutic strategies aimed at restoring lysosomal levels and function. Some of the scientific highlights of the group include the study of the progressive spreading of synucleinopathy through disease modeling.